News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
157,866 Results
Type
Article (5444)
Company Profile (22)
Press Release (152400)
Section
Business (41262)
Career Advice (66)
Deals (7637)
Drug Delivery (6)
Drug Development (25677)
Employer Resources (5)
FDA (4702)
Job Trends (3720)
News (80030)
Policy (8216)
Tag
Academia (579)
Alliances (10485)
Alzheimer's disease (304)
Approvals (4725)
Artificial intelligence (73)
Bankruptcy (58)
Best Places to Work (3458)
Breast cancer (111)
Cancer (731)
Cardiovascular disease (45)
Career advice (62)
Cell therapy (89)
Clinical research (21182)
Collaboration (263)
Compensation (131)
COVID-19 (1790)
C-suite (48)
Data (762)
Diabetes (48)
Diagnostics (1945)
Earnings (19477)
Events (24500)
Executive appointments (228)
FDA (5071)
Funding (220)
Gene therapy (73)
GLP-1 (99)
Government (1207)
Healthcare (4373)
Infectious disease (1840)
IPO (3421)
Job creations (556)
Job search strategy (60)
Layoffs (44)
Legal (1644)
Lung cancer (114)
Lymphoma (58)
Manufacturing (66)
Medical device (2817)
Medtech (2817)
Mergers & acquisitions (4401)
Metabolic disorders (109)
Neuroscience (419)
NextGen: Class of 2025 (712)
Non-profit (773)
Northern California (647)
Obesity (41)
Parkinson's disease (35)
Patents (39)
People (10512)
Phase I (5834)
Phase II (8954)
Phase III (8096)
Pipeline (224)
Postmarket research (956)
Preclinical (2170)
Press Release (54)
Prostate cancer (34)
Radiopharmaceuticals (66)
Rare diseases (79)
Real estate (1097)
Regulatory (5928)
Research institute (669)
Series A (40)
Southern California (494)
Startups (455)
United States (7036)
Vaccines (291)
Date
Today (16)
Last 7 days (308)
Last 30 days (1152)
Last 365 days (11517)
2025 (1579)
2024 (10823)
2023 (10275)
2022 (14252)
2021 (15448)
2020 (15196)
2019 (9338)
2018 (6865)
2017 (6860)
2016 (6472)
2015 (7848)
2014 (5710)
2013 (4764)
2012 (5452)
2011 (5653)
2010 (5671)
Location
Africa (94)
Asia (7688)
Australia (874)
California (1463)
Canada (544)
China (105)
Colorado (94)
Connecticut (114)
Delaware (74)
Europe (18345)
Florida (177)
Georgia (42)
Illinois (130)
Indiana (53)
Japan (66)
Maryland (156)
Massachusetts (1201)
Michigan (28)
Minnesota (65)
New Hampshire (63)
New Jersey (1200)
New York (624)
North Carolina (799)
Northern California (647)
Ohio (39)
Pennsylvania (250)
South America (220)
Southern California (494)
Texas (261)
Virginia (37)
Washington State (141)
Wisconsin (31)
157,866 Results for "qiagen n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast
January 15, 2025
·
1 min read
QIAGEN N.V. to release results for Q1 2024 and hold webcast
QIAGEN N.V. announced plans to release results for the first quarter 2024.
April 9, 2024
·
1 min read
Press Releases
QIAGEN N.V. to release results for Q3 2024 and hold webcast
October 10, 2024
·
1 min read
Press Releases
QIAGEN N.V. to release results for Q4 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter and full year 2023.
January 11, 2024
·
1 min read
Business
QIAGEN N.V. to release results for Q3 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the third quarter 2023.
October 9, 2023
·
1 min read
Press Releases
QIAGEN delivers solid Q4 2024 growth ahead of outlook
February 5, 2025
·
7 min read
Business
QIAGEN N.V. to release results for Q2 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter 2023.
July 24, 2023
·
1 min read
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
QIAGEN N.V. announced a series of new products to further enhance cancer research as well as to enable urine collection and stabilization as a new approach for liquid biopsy.
April 3, 2024
·
8 min read
Press Releases
QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase
January 13, 2025
·
6 min read
Press Releases
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million
January 16, 2025
·
7 min read
1 of 15,787
Next
